AVIVA STRATEGIES (FKA MGB CONSULTING)

Lobbying for ELEMENT BIOSCIENCES · Biotechnology

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $39,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Health Issues

- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025

Medical/Disease Research/Clinical Labs

- National Security Commission on Emerging Biotechnology

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.